These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 23161490)

  • 1. Augmenting antitumor T-cell responses to mimotope vaccination by boosting with native tumor antigens.
    Buhrman JD; Jordan KR; U'ren L; Sprague J; Kemmler CB; Slansky JE
    Cancer Res; 2013 Jan; 73(1):74-85. PubMed ID: 23161490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improving antigenic peptide vaccines for cancer immunotherapy using a dominant tumor-specific T cell receptor.
    Buhrman JD; Jordan KR; Munson DJ; Moore BL; Kappler JW; Slansky JE
    J Biol Chem; 2013 Nov; 288(46):33213-25. PubMed ID: 24106273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electroporation as a "prime/boost" strategy for naked DNA vaccination against a tumor antigen.
    Buchan S; Grønevik E; Mathiesen I; King CA; Stevenson FK; Rice J
    J Immunol; 2005 May; 174(10):6292-8. PubMed ID: 15879128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peptide vaccines prevent tumor growth by activating T cells that respond to native tumor antigens.
    Jordan KR; McMahan RH; Kemmler CB; Kappler JW; Slansky JE
    Proc Natl Acad Sci U S A; 2010 Mar; 107(10):4652-7. PubMed ID: 20133772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced immunogenicity and antitumour effects with heterologous prime-boost regime using vaccines based on MG7-Ag mimotope of gastric cancer.
    Lin T; Liang S; Meng F; Han Q; Guo C; Sun L; Chen Y; Liu Z; Yu Z; Xie H; Ding J; Fan D
    Clin Exp Immunol; 2006 May; 144(2):319-25. PubMed ID: 16634806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improving T cell responses to modified peptides in tumor vaccines.
    Buhrman JD; Slansky JE
    Immunol Res; 2013 Mar; 55(1-3):34-47. PubMed ID: 22936035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual antigen target-based immunotherapy for prostate cancer eliminates the growth of established tumors in mice.
    Karan D; Dubey S; Van Veldhuizen P; Holzbeierlein JM; Tawfik O; Thrasher JB
    Immunotherapy; 2011 Jun; 3(6):735-46. PubMed ID: 21668311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epitope-specific antibody response to Mel-CAM induced by mimotope immunization.
    Hafner C; Wagner S; Jasinska J; Allwardt D; Scheiner O; Wolff K; Pehamberger H; Wiedermann U; Breiteneder H
    J Invest Dermatol; 2005 Jan; 124(1):125-31. PubMed ID: 15654965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergy of vaccine strategies to amplify antigen-specific immune responses and antitumor effects.
    Grosenbach DW; Barrientos JC; Schlom J; Hodge JW
    Cancer Res; 2001 Jun; 61(11):4497-505. PubMed ID: 11389081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relating TCR-peptide-MHC affinity to immunogenicity for the design of tumor vaccines.
    McMahan RH; McWilliams JA; Jordan KR; Dow SW; Wilson DB; Slansky JE
    J Clin Invest; 2006 Sep; 116(9):2543-51. PubMed ID: 16932807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of Tumor Antigen-Specific T-Cell Responses After Oncolytic Vaccination.
    Pol JG; Bridle BW; Lichty BD
    Methods Mol Biol; 2020; 2058():191-211. PubMed ID: 31486039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TCR hypervariable regions expressed by T cells that respond to effective tumor vaccines.
    Jordan KR; Buhrman JD; Sprague J; Moore BL; Gao D; Kappler JW; Slansky JE
    Cancer Immunol Immunother; 2012 Oct; 61(10):1627-38. PubMed ID: 22350070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concurrent vaccination with two distinct vaccine platforms targeting the same antigen generates phenotypically and functionally distinct T-cell populations.
    Boehm AL; Higgins J; Franzusoff A; Schlom J; Hodge JW
    Cancer Immunol Immunother; 2010 Mar; 59(3):397-408. PubMed ID: 19756595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor antigen-specific T-cell expansion is greatly facilitated by in vivo priming.
    Dang Y; Knutson KL; Goodell V; dela Rosa C; Salazar LG; Higgins D; Childs J; Disis ML
    Clin Cancer Res; 2007 Mar; 13(6):1883-91. PubMed ID: 17363545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD4-directed peptide vaccination augments an antitumor response, but efficacy is limited by the number of CD8+ T cell precursors.
    Hanson HL; Kang SS; Norian LA; Matsui K; O'Mara LA; Allen PM
    J Immunol; 2004 Apr; 172(7):4215-24. PubMed ID: 15034034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Antitumor Effects of Vaccine-Activated CD8
    Wu S; Zhu W; Peng Y; Wang L; Hong Y; Huang L; Dong D; Xie J; Merchen T; Kruse E; Guo ZS; Bartlett D; Fu N; He Y
    Cancer Immunol Res; 2017 Oct; 5(10):908-919. PubMed ID: 28851693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vector-based vaccine/cytokine combination therapy to enhance induction of immune responses to a self-antigen and antitumor activity.
    Aarts WM; Schlom J; Hodge JW
    Cancer Res; 2002 Oct; 62(20):5770-7. PubMed ID: 12384537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Superior tumor protection induced by a cellular vaccine carrying a tumor-specific T helper epitope by genetic exchange of the class II-associated invariant chain peptide.
    van Bergen J; Camps M; Offringa R; Melief CJ; Ossendorp F; Koning F
    Cancer Res; 2000 Nov; 60(22):6427-33. PubMed ID: 11103809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human dendritic cells transfected with renal tumor RNA stimulate polyclonal T-cell responses against antigens expressed by primary and metastatic tumors.
    Heiser A; Maurice MA; Yancey DR; Coleman DM; Dahm P; Vieweg J
    Cancer Res; 2001 Apr; 61(8):3388-93. PubMed ID: 11309297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of Enhanced Vaccine Mimotopes for the p15E Murine Cancer Antigen.
    Zhou S; Song Y; Luo Y; Quinn B; Jiao Y; Long MD; Abrams SI; Lovell JF
    Cancer Res Commun; 2024 Apr; 4(4):958-969. PubMed ID: 38506662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.